Tj Biopharma Co., Ltd.
Clinical trials sponsored by Tj Biopharma Co., Ltd., explained in plain language.
-
New hope for rare immune storm: experimental drug targets severe MAS
Disease control Recruiting nowThis study tests an experimental drug called plonmarlimab in 30 people aged 16 to 80 who have a rheumatic disease and a severe immune overreaction known as MAS that has not responded to prior treatments. The goal is to see if the drug can control the overactive immune system and …
Phase: PHASE3 • Sponsor: TJ Biopharma Co., Ltd. • Aim: Disease control
Last updated May 18, 2026 12:08 UTC
-
New gout drug aims to crush flare pain in 72 hours
Symptom relief Recruiting nowThis study tests a new medicine, punarlimab, for people with acute gouty arthritis (sudden, painful joint flares). About 170 adults who have had at least 3 gout attacks in the past year will receive either punarlimab or an active comparator. The main goal is to see how well punar…
Phase: PHASE2 • Sponsor: TJ Biopharma Co., Ltd. • Aim: Symptom relief
Last updated May 26, 2026 11:18 UTC
-
Healthy men needed to compare two forms of TJ101 injection
Knowledge-focused Recruiting nowThis study enrolls 96 healthy adult men in China to see if two versions of TJ101 injection (before and after a manufacturing change) are bioequivalent. Participants receive a single shot of each version in random order, and researchers measure drug levels in the blood. There is n…
Phase: PHASE1 • Sponsor: TJ Biopharma Co., Ltd. • Aim: Knowledge-focused
Last updated May 26, 2026 11:12 UTC